Feedback / Questions
GT801 - Grit Biotechnology
https://www.prnewswire.com/news-releases/vivacta-bio-announces-promising-first-in-human-results-for-gt801-an-in-vivo-car-t-therapy-in-non-hodgkins-lymphoma-at-the-2025-ash-annual-meeting-302633966.html
Dec 6, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next